Faculties kkk



                                                  Email:      kli@epigenetic.us





  • Testimonials

  • Community



    Newest Protocols

    New Book1 --- <<Epigenetics>>. Read online

    New Book2 --- <<Epigenetic Targets in Drug Discovery>>

    Read online

    New Published Papers





    It is always people who make the difference. Whether it's a patient with the tenacity to keep fighting or a scientist whose life is dedicated to finding the cure, it couldn't happen without their courage and caring.

    Dr. Arthur Zelent, Leukaemia Research Fund Center, London, England: Dr. Zelent is a team leader at the largest cancer center in Europe. He's been working to identify gene defects and testing compound substances that might trigger self-correction. Dr. Zelent's team discovered why the use of retinoic acid induces differentiation (self-correction) of acute promyelocytic leukemia (APL) cells.

    "Once compounds are identified, it's a long way to the final stage. "

    -- Dr. Arthur Zelent

    Individuals with APL who were treated with retinoic acid experienced full remissions. Dr. Zeland believes that, in the future, melanoma cells are a promising possibility for this kind of treatment.

    Header image

    Leave Message



    Sept. 2010, during Shanghai Institute of Hematology  and Samuel Waxman Cancer Research Foundation Co-PI meeting, the Co-PIs visited Shanghai Institute of Materia Medica, Chinese Academy of Sciences. 

    Oct. 2010,  Shanghai Institute of Hematology was visited by  professor Bruce Alberts, who currently is the editor in chief of Science, and was the president of United  National Academy of Sciences from 1993 to 2005.



     Nov. 2010,  Co-sponsored by US-SINO EPIGENETIC ASSOCIATION, professor Ronen Marmorstein from Wistar Institute & University of Pennsylvania,  visited Shanghai and Beijing. We sponsored his lectures in Shanghai Insitute of Materia Medica, Shanghai Jiaotong University, Tsinghua University Medical School, Institute of Biophysics.